next generation semaglutide ⚖️ SEMAGOS vs TIRGOS — Transforming diabetes care & weight management with next-generation GLP-1 & GIP innovation. 💉✨ Better science. Better outcomes. Better Health. 💙 #semaglutide #ᴡᴇɪɢʜᴛʟᴏssᴊᴏᴜʀɴᴇʏ Peptide Therapy and Semaglutide Champions

Struyf S, Proost P, Van Damme J

[4] The nature of the compounded formulation of testosterone cypionate means inactive components, usually limited to grapeseed oil and possibly a bacteriostatic agent, can be adjusted to address allergies or other patient-specific considerations, thereby offering flexibility beyond what is available with a single commercial brand while still requiring physician oversight and periodic laboratory monitoring to ensure both efficacy and safety

Senescent Leydig Cell Elimination & Testosterone Restoration in Aged Mice (Aging / PMC, 2020) FOXO4-DRI Disrupts FOXO4-p53 in Senescent Leydig Cells and Improves Testicular Microenvironment A study published in Aging (and indexed on PMC) demonstrated that FOXO4 is specifically expressed in human Leydig cells, with nuclear translocation of FOXO4 in elderly men correlating with decreased testosterone synthesis

Glucagon receptor activation drives energy expenditure and thermogenesis, allowing researchers to study both energy intake suppression and active caloric expenditure simultaneously a mechanistic capability not available with GIP/GLP-1 dual agonists or GLP-1 mono agonists

Diabetes Obes Metab 2017;19:33647

doi:10.1056/NEJMoa2206038 Rosenstock J, Wysham C, Fras JP, et al